Lorazepam

Product NDC
62135-549
11-digit product format
621350549
Labeler code
62135
Product ID
62135-549_044c464b-af13-d50f-e063-6394a90ade25
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lorazepam
Dosage form
CONCENTRATE
Route
ORAL
Labeler
Chartwell RX, LLC
Application
ANDA079244
Marketing category
ANDA
Marketing start
2009-04-28
Substance
LORAZEPAM
Active strength
2 mg/mL
Pharmacologic classes
Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079244-001LORAZEPAMLORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-283f01610625f2…
2019-09-15 20:21 UTC2019-09A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORALAA2009-04-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A079244-001LORAZEPAM2MG/MLCONCENTRATE / ORAL2009-04-28e64feba35796…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079244-001AA15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079244-001AA15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079244-001AA14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079244-001AA174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079244-001AA1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079244-001AA1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079244-001AA187673890dc5c…
2021-03-12 10:30 UTC2021-03A079244-001AA15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079244-001AA18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079244-001AA1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079244-001AA13f01610625f2…
2019-09-15 20:21 UTC2019-09A079244-001AA1b00525d2431f…
2019-07-19 19:46 UTC2019-07A079244-001AA1ea99ee380514…

Additional Listing Data#

Finished product
Yes
Brand name base
Lorazepam
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LORAZEPAM2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O26FZP769LInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
311376Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e075c78d-f0c6-4380-b769-bb8833d23ba5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a759f740-8682-4896-9194-8b6c103c9aeeProduct name320250716
b7badb1c-6d3f-4f95-a4ca-ce69992e58a1Product name120220308
5d98a0ba-a64b-d9b2-e6ec-87edbb57a285Product name220180320
ac8efea8-f412-295f-00ce-b095e5cbc115Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62135-549-43Lorazepam30 mL in 1 BOTTLECONCENTRATE302

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62135-549-43ML - Milliliter62135-5493dc91b6a-e7ca-42a2-b234-d4840a0e14f512023-10-16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62135-549LORAZEPAM CONCENTRATE [CHARTWELL RX, LLC]2Current NDC, 1 package rows20230902_e075c78d-f0c6-4380-b769-bb8833d23ba5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LorazepamLORAZEPAMChartwell RX, LLCe075c78d-f0c6-4380-b769-bb8833d23ba52023-09-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079244
application number: ANDA079244
ndc (product): 62135-549

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311376LORazepam 2 MG in 1 mL Concentrate for Oral SolutionPSNe075c78d-f0c6-4380-b769-bb8833d23ba52
311376lorazepam 2 MG/ML Oral SolutionSCDe075c78d-f0c6-4380-b769-bb8833d23ba52
311376lorazepam 2 MG per 1 ML Concentrate for Oral SolutionSYe075c78d-f0c6-4380-b769-bb8833d23ba52

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
62135-549-436213505494330 mL in 1 BOTTLE (62135-549-43) 30 ml2023-04-20NoNoCurrent